EZH2 and breast cancer: Interestingly, we observed that the positive rates of EZH2 and NSD2 protein expression in TNBC were higher than that in other molecular subtypes of BC, including luminal A, luminal B and HER2-enriched BC (P = 0.033, P = 0.026, Table 4).